5 hours Here’s Why Pfizer (PFE) is a Strong Value Stock Zacks

   X     

2 days Why Pfizer (PFE) Outpaced the Stock Market Today Zacks

   X     

3 days Pfizer CEO: Americans can expect radical change from this upcoming Trump administration YouTube

   X     

3 days Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock Zacks

   X     

1 week Pfizer to sell $3 billion stake in Sensodyne maker Haleon Investing.com

   X     

1 week Pfizer Sells 700 Million Haleon Shares for $3 Billion The Wall Street Journal

   X     

1 week Pfizer Sells 700 Million Haleon Shares for $3.05 Billion Yahoo Finance

   X     

1 week Pfizer (PFE) Stock Falls Amid Market Uptick: What Investors Need to Know Zacks

   X     

1 week Pfizer appeals denial of $75 million claim in SEC case against Cohen hedge fund Yahoo Finance

   X     

1 week Pfizer to cut stake in Sensodyne-maker Haleon to 7.3%, says bookrunner Investing.com

   X     

1 week Pfizer to sell 7.7% stake in Haleon for potential $3.1 billion, Bloomberg reports Investing.com

   X     

1 week Pfizer to cut stake in Sensodyne-maker Haleon to 7.3%, says bookrunner Yahoo Finance

   X     

1 week Pfizer CEO Albert Bourla: Our 2025 focus is on pipeline YouTube

   X     

1 week Pfizer Inc. (PFE) 43rd Annual J.P. Morgan Healthcare Conference (Transcript) Seeking Alpha

   X     

1 week Pfizer Meets Goal in Non-Muscle Invasive Bladder Cancer Study Zacks

   X     

2 weeks Pfizer: My Top Play In 2025 Using Dogs Of The Dow Strategy Seeking Alpha

   X     

2 weeks Pfizer must face lawsuit over diversity fellowship program, US court rules Investing.com

   X     

2 weeks Pharma Stock Roundup: FDA Updates for JNJ, GSK, PFE, NVO’s Expanded Deal Zacks

   X     

2 weeks Pfizer (PFE) Stock Drops Despite Market Gains: Important Facts to Note Zacks

   X     

2 weeks GSK, Pfizer RSV shots must warn about rare paralysis risk Fortune

   X     

2 weeks Dividend Roundup: Why I Prefer Johnson & Johnson Over Pfizer Seeking Alpha

   X     

2 weeks FDA requires GSK and Pfizer vaccines to carry rare side effect warnings Investing.com

   X     

2 weeks Why Pfizer (PFE) is a Top Value Stock for the Long-Term Zacks

   X     

2 weeks Is Trending Stock Pfizer Inc. (PFE) a Buy Now? Zacks

   X     

3 weeks Pfizer has increased prices on over 60 drugs in the U.S. as of Jan. 1 Fortune

   X     

3 weeks Pfizer Rises 5.6% in a Month: How Should You Play the Stock? Zacks

   X     

3 weeks Pharma Stock Roundup: PFE Ends Hemophilia Deal With SGMO & More Zacks

   X     

3 weeks Pfizer: A Step-By-Step Strategy Before Earnings Seeking Alpha

   X     

3 weeks The Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer Zacks

   X     

3 weeks The Zacks Analyst Blog Berkshire Hathaway, The Home Depot, Pfizer and AMREP Zacks

   X     

3 weeks Pfizer (PFE) Advances While Market Declines: Some Information for Investors Zacks

   X     

3 weeks Top Research Reports for Berkshire Hathaway, Home Depot & Pfizer Zacks

   X     

3 weeks Here’s Why Pfizer (PFE) is a Strong Momentum Stock Zacks

   X     

3 weeks Sangamo Therapeutics Stock Plummets 56% After Pfizer Ends Hemophilia Treatment Partnership Yahoo Finance

   X     

3 weeks Pfizer’s 2025 Comeback: What’s Driving Growth Seeking Alpha

   X     

3 weeks 2025 drug price rise: Pharma companies plan to make more than 250 medicines more expensive Fast Company

   X     

3 weeks Sangamo Therapeutics’ stock falls the most in 16 years after Pfizer ends hemophilia pact MarketWatch

   X     

3 weeks Sangamo Therapeutics Stock Crashes as Pfizer Ends Hemophilia Drug Pact Yahoo Finance

   X     

3 weeks Sangamo Therapeutics Stock Plummets 56% After Pfizer Ends Hemophilia Treatment Partnership Yahoo Finance

   X     

3 weeks Sangamo Plunges After Pfizer Ends Pact for Hemophilia Drug Yahoo Finance

   X     

3 weeks Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact Yahoo Finance

   X     

3 weeks Sangamo’s stock sinks 50% as Pfizer halts haemophilia A gene therapy partnership Yahoo Finance

   X     

3 weeks NIH settlement ‘manageable headwind’ for BioNTech, Pfizer, says Morgan Stanley Yahoo Finance

   X     

3 weeks 3 Reasons to Buy Pfizer Stock Like There’s No Tomorrow Yahoo Finance

   X     

3 weeks Sangamo stock crashes 50% after Pfizer terminates HemoA gene therapy deal Investing.com

   X     

3 weeks SGMO Stock Crashes as Pfizer Ends Deal for Hemophilia Candidate Zacks

   X     

3 weeks Pfizer ends global collaboration with Sangamo, shares drop 27% Investing.com

   X     

3 weeks Pfizer: One Of The Next Big AI Winners Seeking Alpha

   X     

4 weeks Pfizer (PFE) Suffers a Larger Drop Than the General Market: Key Insights Zacks

   X     

4 weeks Pharma Stock Roundup: NVO’s Obesity Study Failure, FDA Nod to PFE, LLY Zacks

   X     

4 weeks Pfizer: Why I’m Staying On The Sidelines Seeking Alpha

   X     

4 weeks Better Income Stock: Pfizer or Altria Group? Yahoo Finance

   X     

1 month Pfizer: Time And Patience Ran Out (Rating Downgrade) Seeking Alpha

   X     

1 month Should Value Investors Buy Pfizer (PFE) Stock? Zacks

   X     

1 month Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know Zacks

   X     

1 month Pfizer’s 2025 ‘Boring’ Outlook Had A Nice Surprise That Was Overlooked Seeking Alpha

   X     

1 month Pharma Stock Roundup: PFE’s 2025 Outlook, MRK & ABBV’s M&A Deals Zacks

   X     

1 month Market Digest: ACN, ATO, OGE, PFE, PNW, JCI, DASH Yahoo Finance

   X     

1 month Why Pfizer (PFE) Dipped More Than Broader Market Today Zacks

   X     

1 month Pfizer Momentum Shift Makes Me Less Bullish (Technical Analysis) Seeking Alpha

   X     

1 month Pfizer: I’m Short-Term Skeptical, Long-Term Positive Post 2025 Guidance Call Seeking Alpha

   X     

1 month Pfizer Stock Up 5% as 2025 Guidance Meets Investor Expectations Zacks

   X     

1 month Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy Investor's Business Daily

   X     

1 month Final Trade: GOOG, SAIA, X, PFE YouTube

   X     

1 month Pfizer climbs 4% on 2025 outlook YouTube

   X     

1 month Comments From Trump, Pfizer CEO Hit UnitedHealth, CVS Stock Yahoo Finance

   X     

1 month Stocks making the biggest moves midday: Pfizer, Broadcom, Teva Pharmaceuticals and more CNBC

   X     

1 month Pfizer Inc. (PFE) Full-Year 2025 Financial Guidance Conference Call (Transcript) Seeking Alpha

   X     

1 month Guggenheim: Can see Pfizer reaching $10 billion in sales by 2030 YouTube

   X     

1 month Pfizer 2025 profit forecast soothes investor jitters as it pursues turnaround Investing.com

   X     

1 month Pfizer Stock Jumps On Mixed, But ‘Marginally Encouraging,’ 2025 Outlook Investor's Business Daily

   X     

1 month Stocks making the biggest moves premarket: Pfizer, Tesla, SolarEdge, Red Cat and more CNBC

   X     

1 month Pfizer Sees 2025 Revenue in Line With Wall Street Views The Wall Street Journal

   X     

1 month AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back? Investor's Business Daily

   X     

1 month Nvidia, Evgo and Affirm fall premarket; Pfizer and SolarEdge rise Investing.com

   X     

1 month Pfizer forecasts in line 2025 profit as it seeks turnaround Investing.com

   X     

1 month Pfizer Sees 2025 Revenue in Line With Wall Street Views Yahoo Finance

   X     

1 month Pfizer Stock Rises as Drug Giant Sees 2025 Revenue of $61 Billion to $64 Billion Yahoo Finance

   X     

1 month Pfizer projects 2025 earnings to align with expectations Investing.com

   X     

1 month Pfizer forecasts 2025 profit in line with expectations as it seeks turnaround CNBC

   X     

1 month Pfizer forecasts 2025 profit in line with expectations Investing.com

   X     

1 month These Stocks Are Moving the Most Today: Nvidia, Tesla, Broadcom, Pfizer, EVgo, Teva, SolarEdge, Red Cat, and More Yahoo Finance

   X     

1 month Stocks to Watch Recap: SoftBank, Pfizer, Super Micro, Affirm Yahoo Finance

   X     

1 month What To Expect When Pfizer Outlines Its 2025 Financial Outlook On Tuesday? Yahoo Finance

   X     

1 month Pfizer: Lowest Levels In A Decade Is An Opportunity With A Dividend Yield Exceeding 6.5% Seeking Alpha

   X     

1 month Pfizer: Irrational Anti-Vaccine Fear Seeking Alpha

   X     

1 month Is Pfizer a Millionaire Maker? Yahoo Finance

   X     

1 month How Pfizer management outplayed activist investor Starboard Yahoo Finance

   X     

1 month Pfizer (PFE) Stock Falls Amid Market Uptick: What Investors Need to Know Zacks

   X     

1 month Pfizer: Peer-Leading Dividend And Potential Substantial Shareholder Returns Seeking Alpha

   X     

1 month Amazon, Pfizer execs seek common ground with RFK Jr on climate risks to health Investing.com

   X     

1 month Pfizer Stock: A Golden Buying Opportunity (Rating Upgrade) Seeking Alpha

   X     

2 months Zacks.com featured highlights Urban Outfitters, Maplebear, Pfizer and Alcoa Zacks

   X     

2 months Trump, RFK Jr. met with Pfizer, Lilly executives, Axios reports Investing.com

   X     

2 months Pfizer: Too Cheap To Ignore Seeking Alpha

   X     

2 months Pfizer Stock Falls 8% in a Month: Should You Buy the Dip? Zacks

   X     

2 months Should You Forget Pfizer and Buy These Unstoppable Stocks Instead? Yahoo Finance

   X     

2 months Pfizer’s New Chief Scientific Officer Charts R&D Vision For High And Low-Risk Investments Yahoo Finance

   X     

2 months Zacks.com featured highlights Tyson Foods, AXIS Capital, Pfizer and General Motors Zacks

   X     

2 months Mastercard, Broadcom, Pfizer Among Two Dozen Companies To Announce Dividend Increases In December Seeking Alpha

   X